Gelomics
Gelomics operates as a biotechnology company.
Backed by
Queensland Investment Corporation
Angelloop
Jelix VenturesRaised 2.2M SEED on July 8, 2024
About
Gelomics is a biotechnology service provider that offers 3D cell-culture platforms and related laboratory services for cellular assays and tissue modeling.
Mission
Gelomics is a biotechnology service provider focused on 3D cell-culture technology. The company’s core offering is 3D cell culture as part of its service portfolio. According to the report, Gelomics recently completed a $2.2 million seed financing. Participating investors in the round were Queensland Investment Corporation, AngelLoop, and Jelix Ventures. The article does not provide additional operational metrics, founding-year information, or location details.
Quick Facts
Founded
2018
Funding
SEED
Industry
Biotechnology, Medical
Team Size
11-50
Headquarters
Kelvin Grove, Queensland, Australia
Careers
View Careers Page
No open roles at this time.
Check their careers page for updates